CIK 0001372299
- Non-accelerated filer
- Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,088,801
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,088,801. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-08 | Lewis Michael Director | Option exercise | +403,845 | 4,014,415 | ||
| 2019-02-08 | Lewis Michael Director | Option exercise | +1,244,444 | 5,258,859 | ||
| 2019-02-08 | Lewis Michael Director | Option exercise · Common Stock Warrant (Right to Buy) | +403,845 | 0 | ||
| 2019-02-08 | Lewis Michael Director | Option exercise · Common Stock Warrant (Right to Buy) | +1,244,444 | 0 | ||
| 2018-10-10 | Lewis Michael Director | Purchase | +538,460 | 3,610,570 | ||
| 2018-10-10 | Lewis Michael Director | Purchase · Common Stock Warrant (Right to Buy) | +403,845 | 403,845 | ||
| 2018-06-15 | Lewis Michael Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2017-06-13 | Lewis Michael Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2016-12-16 | Lewis Michael Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2016-12-02 | Lewis Michael Director | Conversion | +996,779 | 3,072,110 | ||
| 2016-12-02 | Lewis Michael Director | Conversion · Series A Convertible Preferred Stock | −2,242.75 | 0 | ||
| 2016-09-29 | Lewis Michael Director | Grant or award | +247,665 | $2.25 | $557K | 2,075,331 |
| 2016-09-29 | Lewis Michael Director | Grant or award · Series A Convertible Preferred Stock | −2,242.75 | $1,000.00 | $2.2M | 0 |
| 2016-09-29 | Lewis Michael Director | Grant or award · Common Stock Warrant (Right to Buy) | −1,244,444 | 0 | ||
| 2015-06-24 | Lewis Michael Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2015-06-01 | Lewis Michael Director | Other disposition | −89,441 | 1,827,666 | ||
| 2014-12-08 | Lewis Michael Director | Conversion | +747,000 | 1,036,244 | ||
| 2014-12-08 | Lewis Michael Director | Conversion | +492,618 | 1,528,862 | ||
| 2014-12-08 | Lewis Michael Director | Option exercise | +11,502 | $0.76 | $9K | 1,540,364 |
| 2014-12-08 | Lewis Michael Director | Sale | −792 | $11.00 | $9K | 1,539,572 |
Page 1 of 2 · 25 trades